This Open-Source AI Tries to Reject Bad Drug Ideas Before the Lab Does

PeptiVerse predicts several make-or-break properties of peptide drug candidates before researchers synthesize them, potentially saving time and money. The open-source system performed strongly on curated benchmarks, but its predictions are filters, not experimental proof that a molecule is safe or effective.